{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2021", "item": "https://www.patentleaderboard.com/2021/"}, {"@type": "ListItem", "position": 3, "name": "Amgen", "item": "https://www.patentleaderboard.com/2021/company/amgen"}, {"@type": "ListItem", "position": 4, "name": "Matthew P. Bourbeau", "item": "https://www.patentleaderboard.com/2021/inventor/fl:ma_ln:bourbeau-1"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
MB

Matthew P. Bourbeau — 4 Patents in 2021

AMAmgen: 4 patents #17 of 505Top 4%
Calabasas, CA: #18 of 324 inventorsTop 6%
California: #5,616 of 66,859 inventorsTop 9%
Overall (2021): #45,004 of 548,734Top 9%
4 Patents 2021

Issued Patents 2021

Showing 1–4 of 4 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
11021493 1,4-thiazine dioxide and 1,2,4-thiadiazine dioxide derivatives as beta-secretase inhibitors and methods of use Jennifer R. Allen, James Brown, Ning Chen, Michael J. Frohn, Zice Fu +6 more 2021-06-01 $258,451,000
10947223 Substituted oxazines as beta-secretase inhibitors Jennifer R. Allen, Ning Chen, Michael J. Frohn, Paul E. Harrington, Qingyian Liu +1 more 2021-03-16 $1,023,364,000
10889579 Thiazine derivatives as β-secretase inhibitors and methods of use Paul E. Harrington, Qingyian Liu 2021-01-12 $484,084,000
10889581 Cyclopropyl fused thiazine derivatives as beta-secretase inhibitors and methods of use Jennifer R. Allen, Albert Amegadzie, Jian Chen, Michael J. Frohn, Paul E. Harrington +5 more 2021-01-12 $484,084,000